Alopecia areata
☆ AI Dermatology — Free Service
ໃນປີ 2022 Stiftung Warentest ຜົນໄດ້ຮັບຈາກເຢຍລະມັນ, ຄວາມພໍໃຈຂອງຜູ້ບໍລິໂພກກັບ ModelDerm ແມ່ນຕໍ່າກວ່າການປຶກສາຫາລືທາງດ້ານການປິ່ນປົວທາງໂທລະສັບເລັກນ້ອຍເທົ່ານັ້ນ.
ໃນປີ 2022 Stiftung Warentest ຜົນໄດ້ຮັບຈາກເຢຍລະມັນ, ຄວາມພໍໃຈຂອງຜູ້ບໍລິໂພກກັບ ModelDerm ແມ່ນຕໍ່າກວ່າການປຶກສາຫາລືທາງດ້ານການປິ່ນປົວທາງໂທລະສັບເລັກນ້ອຍເທົ່ານັ້ນ.
Alopecia areata ເຫັນຢູ່ດ້ານຫຼັງຂອງໜັງຫົວ. ໃນກໍລະນີປົກກະຕິ, ມັນຈະປາກົດຂຶ້ນຢ່າງກະທັນຫັນດ້ວຍຫນ້າກ້ຽງຫມົດ ແລະ ມີຂະໜາດ 2–3 ຊມ.
relevance score : -100.0%
ReferencesAlopecia areata ເປັນເງື່ອນໄຂທີ່ລະບົບພູມຕ້ານທານຂອງຜູ້ໂຈມຕີຮາກຜົມ, ເຮັດໃຫ້ຜົມຫຼົ່ນຊົ່ວຄາວໂດຍບໍ່ມີຮອຍແປ້ວ. ມັນສາມາດເຮັດໃຫ້ເຫັນການສູນເສຍຜົມ ຫຼື ມີຜົນກະທົບຕໍ່ຫນັງຫົວ ແລະ ຮ່າງກາຍ, ຜົນກະທົບປະມານ 2% ຂອງປະຊາຊົນໃນບາງຂັ້ນຕອນຂອງຊີວິດ. ສາເຫດທີ່ສ້າງຂຶ້ນຈາກການປົກປັກຮັກສາທໍາມະຊາດອ້ອມຂ້າງຮາກຜົມ.
Alopecia areata is an autoimmune disorder characterized by transient, non-scarring hair loss and preservation of the hair follicle. Hair loss can take many forms ranging from loss in well-defined patches to diffuse or total hair loss, which can affect all hair-bearing sites. Patchy alopecia areata affecting the scalp is the most common type. Alopecia areata affects nearly 2% of the general population at some point during their lifetime. A breakdown of immune privilege of the hair follicle is thought to be an important driver of alopecia areata.
Alopecia areata is an autoimmune disorder characterized by transient, non-scarring hair loss and preservation of the hair follicle. Hair loss can take many forms ranging from loss in well-defined patches to diffuse or total hair loss, which can affect all hair-bearing sites. Patchy alopecia areata affecting the scalp is the most common type. Alopecia areata affects nearly 2% of the general population at some point during their lifetime. A breakdown of immune privilege of the hair follicle is thought to be an important driver of alopecia areata.
Alopecia areata ເປັນສະພາບທີ່ລະບົບພູມຄຸ້ມກັນທໍາຮ້າຍຮູຂຸມຂົນ, ເຮັດໃຫ້ຜົມຫຼົ່ນຕາມໜັງຫົວ ແລະສ່ວນທີ່ມີຂົນອື່ນໆຂອງຮ່າງກາຍ. ມັນມີຜົນກະທົບປະມານ 2% ຂອງປະຊາຊົນທົ່ວໂລກ. ໃນຂະນະທີ່ມັນສາມາດເກີດຂຶ້ນໄດ້ໃນທຸກເວລາ, ມັນພົບເລື່ອຍໃນເດັກນ້ອຍຫຼາຍກວ່າຜູ້ໃຫຍ່ (1.92% vs. 1.47%). ແມ່ຍິງ, ໂດຍສະເພາະຜູ້ທີ່ມີອາຍຸຫຼາຍກວ່າ 50 ປີ, ມັກຈະມີປະສົບການຫຼາຍກວ່າຜູ້ຊາຍ. ການສັກຢາ corticosteroids ໂດຍກົງໃສ່ບໍລິເວນທີ່ຖືກກະທົບໄດ້ສະແດງຜົນດີກວ່າການທາຢາ.
Alopecia areata is an immune-mediated condition leading to non-scarring alopecia of the scalp and other hair-bearing areas of the body. It affects up to 2% of the global population. It can affect all ages, but the prevalence appears higher in children compared to adults (1.92%, 1.47%). A greater incidence has been reported in females than males, especially in patients with late-onset disease, defined as age greater than 50 years. Intralesional injection of corticosteroids has been reported to lead to better responses compared to topical steroids.
Alopecia areata is an immune-mediated condition leading to non-scarring alopecia of the scalp and other hair-bearing areas of the body. It affects up to 2% of the global population. It can affect all ages, but the prevalence appears higher in children compared to adults (1.92%, 1.47%). A greater incidence has been reported in females than males, especially in patients with late-onset disease, defined as age greater than 50 years. Intralesional injection of corticosteroids has been reported to lead to better responses compared to topical steroids.
ເຊື່ອກັນວ່າ Alopecia areata ເປັນພະຍາດ autoimmune ທີ່ກ່ຽວຂ້ອງກັບລະບົບພູມຕ້ານທານຂອງຮາກຜົມ. ສາເຫນັງພື້ນຖານແມ່ນການສູນເສຍການປ່ຽນແປງຂອງຮ່າງກາຍໃນການຮັບຮູ້ຈຸລັງຂອງຕົນເອງ, ດ້ວຍການທໍາລາຍລະບົບພູມຕ້ານທານທີ່ສັດຕໍ່ກັນຂອງຮາກຜົມ.
○ ການປິ່ນປົວ ― OTC Drugs
ບາງຄົນທີ່ມີ alopecia areata ອ່ອນໆຈະຟື້ນຕົວພາຍໃນຫນຶ່ງປີ ແບບບໍ່ມີການປິ່ນປົວ. ແນວໃດກໍ່ຕາມ, ຄົນສ່ວນໃຫຍ່ຈະປະສົບການເກີດຂຶ້ນຊ້າຍໃນສະຖານທີ່ສຸ່ມຂອງໜັງຫົວ.
#Hydrocortisone cream
○ ການປິ່ນປົວ
ການສັກຢາ steroid intralesional ແມ່ນວິທີການປິ່ນປົວທີ່ມີປະສິດທິພາບສູງ. ການປິ່ນປົວດ້ວຍພູມຕ້ານທານສາມາດໃຊ້ໄດ້ ຖ້າພື້ນທີ່ຂະໜາດໃຫຍ່ຂອງຫນັງຫົວມີຜົນກະທົບ.
#Triamcinolone intralesional injection
#DPCP immunotherapy